This Evidence to Practice report assesses the comparative clinical effectiveness, cost-effectiveness, and potential budget impact of the CardioMEMS HF system relative to standard heart failure management.
Article InformationCorresponding Author: Daniel A. Ollendorf, PhD, Institute for Clinical and Economic Review, Two Liberty Square, 9th Floor, Boston, MA 02109 (firstname.lastname@example.org).
Published Online: September 6, 2016. doi:10.1001/jamainternmed.2016.5467
Conflict of Interest Disclosures: None reported.
Funding/Support: The California Technology Assessment Forum is a program of the Institute for Clinical and Economic Review and is supported by grants from the BlueShield of California Foundation, the California HealthCare Foundation, and the Laura and John Arnold Foundation.
Role of the Funder/Sponsor: The funders/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We wish to acknowledge the contributions of the following individuals to the development of this manuscript: Richard Chapman, PhD; Elizabeth Russo, MD; Matthew Seidner; Patricia Synnott, MALD, MS; and Jed Weissberg, MD, of the Institute for Clinical and Economic Review; as well as Paul Heidenreich, MD, MS; and Jeremy Goldhaber-Fiebert, PhD, of Stanford University School of Medicine. These individuals were not compensated for their contributions.